Paul Henderson Battles Back Against Cancer
Thank you, Toronto Sun for this good news story in your hockey section.
OK, I am still a Canadian.
OK, I am still a huge hockey fan.
OK, I still remember the goal he scored against the Soviets.
When we met in Niagara Falls in 2012 at CLLPAG conference, I suggested he look into the NIH trial for ibrutinib. At that time, I had not yet started ibrutinib, but was still in the ofatumumab stage of the clinical trial at OSU with Dr. John Byrd where I would eventually get ibrutinib and do so well.
I am glad to see he is having the extraordinary success that I and so many others are enjoying with ibrutinib and the other new medications for CLL.
I am moved but his spiritual response to his cancer challenge. Paul is a man of faith and this is the season of miracles.
I hope and pray that the cost of these medicines will not delay their access in Canada- in every province, for every patient that would benefit.
I salute Paul Henderson for getting on a plane and flying to Bethesda. Not everyone has the resources or the knowledge or guts to do that. Not everyone fits the admission criteria for a trial.
I want to build a CLL community where every patient across all borders has the opportunity for the best possible care.
I am traveling, having met with other blood cancer patient advocates in Greece, so I appreciate the Toronto Sun doing my work for me on this post. Little time to write here.
One comment:
The hockey great tells the truth when he says what we know is that ibrutinib will work for about two years, but that is only because that is the best data we have. Only a handful of patients have taken it for around 4 years now and nearly all of those are still cruising along with their disease controlled, but the truth is that most of the data is out about two years or less. The curves are very flat for the treatment naive (those whose first treatment is ibrutinib), meaning that nearly all do not develop resistance and are doing great. In the relapsed and refractory population, the great majority also continue to respond, but there is a slightly bigger drop off. There are clearly some late CLL relapses seen after a year or more on drug, mostly seen in those with genomic instability such as those of us with a deletion 17p. More on this with the exact statistics from the papers at ASH when I get back stateside.
When I get home, I promise that I will write more about the news about CLL from iwCLL and ASH.
But first this feel good article.
BY JOE WARMINGTON ,TORONTO SUN
FIRST POSTED: MONDAY, DECEMBER 16, 2013 09:50 PM EST | UPDATED: MONDAY, DECEMBER 16, 2013 10:48 PM EST
TORONTO -
All Paul Henderson wanted for Christmas was a clean bill of health from his deadly cancer.
It was actually more his wife of 50 years, Eleanor, their three daughters — Heather, Jennifer and Jill — and seven grandkids who were doing the asking.
It was no secret it was wishing for a lot. A miracle may be more what they were praying for.
It was not looking promising.
Just a year ago, the thought that the legendary Canadian hockey hero, suffering from chronic lymphocytic leukemia, would even be around for another Christmas was a dream.
In a column on Henderson in 2012, he was open about his ongoing battle with a rare, often terminal, form of cancer.
“There are signs of it getting worse,” he told me. “I have to admit the tumours are not getting any smaller. The cancer is now in my stomach, chest and lymph nodes.”
He had dropped from 184 pounds to 160 pounds.
The man who scored the winning goal in the final three games of the 1972 Summit Series against the then mighty Soviet Union was running out of both time and options.
But Henderson has been known to thrive in tough circumstances, including scoring the goal of the century with just 34 seconds remaining in the final game in Moscow.
More than 41-years removed, he has proved his flare of beating the odds once again.
“It’s either chemotherapy or a clinical trial,” he said in 2012.
He chose the clinical trial and with fingers crossed went down to Bethesda, Md.
“The tumour in my stomach was the size of a grapefruit,” said Henderson, who was at the Toronto Sun’s downtown offices for an appearance on Michael Coren’s Sun News Network show, The Arena. “My spleen was double the size and the tumours were all over my body including in my armpits and my lymph nodes were swollen.”
Enter an experimental drug, called Ibrutinib, which is now being referred to as “breakthrough” therapy. “I take two little pills in the morning.”
The tumours began to shrink and now while Henderson can’t say his cancer is in remission, it is as close to that as someone with his form of the disease can ever hope for. “In my bones, they said they were 87% affected and now it’s down to 5%,” he added. “And the tumour in my stomach that was the size of the grapefruit is all but gone.” He has put all his weight back on and is back to 184 pounds.
It’s a Christmas Miracle!
“The Lord be good,” was Don Cherry’s reaction.
Henderson said the good news is also that most of the people in his clinical trial have had similar results and that one day Canadians may be able to gain access to this yet-to-be approved treatment.
He is hopeful it could mean that chemotherapy could become a thing of the past.
“When people say it’s a miracle I just say I will wait until I get to heaven and ask,” teased a smiling and upbeat Henderson.
He feels fantastic and looks even better.
“My wife joked she wants to take some of those pills because they must have Botox in them,” he said.
The Hendersons are realistic that with cancer, every day is special.
“I am told that this drug will work, they think for two years, so we don’t know what is going to happen after that.”
But what he does know is Henderson is feeling positive about enjoying Christmas with his family and even his 71st birthday on Jan. 28.
“I feel blessed because my dad died at 49,” he said. “I have never been worried because when you have hope and peace, you can handle anything.”
Henderson said he wouldn’t change a thing.
“I think having the cancer allowed me to be able to freely talk about my faith,” he said.
And, this Christmas, he is also able to reflect on another remarkable do-or-die moment he pulled out from suspected defeat and turned into victory just in the nick of time.
Labels: Canada, Chronic lymphocytic leukemia, Clinical Trial, Clinical trials, CLL, CLLPAG, ibrutinib, NCT01217749, NIH, ofatumumab, OSU, Paul Henderson
4 Comments:
Thanks for posting the article. One line in it hinted at the limited effectiveness of ibrutinib over time: "“I am told that this drug will work, they think for two years, so we don’t know what is going to happen after that.” I don't remember hearing this before - is this something new?
hey nice post mehn. I love your style of blogging here. The way you writes reminds me of an equally interesting post that I read some time ago on Daniel Uyi's blog titled Being A Pick-Up Artist vs Being A Growth-Oriented Person .
keep up the good work.
Regards
I love that the National Institute of Health allows patients from all over the world to participate in this trial !! I'm thrilled that my tax dollars are used so generously and that trials like this will make a wonderful drug available those with this incurable disease.
Thanks Brian as always for your honest and informative posts. And enjoy your travels.
Lynn S.
The 2 years relates to those with 17P from what I have been told. Otherwise I am unaware of failures unless it transformed to Richters.
Post a Comment
Subscribe to Post Comments [Atom]
<< Home